These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2490585)

  • 1. High-performance liquid chromatographic method for the determination of diltiazem and two of its metabolites in human plasma: application to a new sustained release formulation.
    Boucher S; Varin F; Theoret Y; Du Souich P; Caille G
    J Pharm Biomed Anal; 1989; 7(12):1925-30. PubMed ID: 2490585
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioequivalence of two pharmaceutical forms of diltiazem.
    Rubio M; Masana MI; Garcilazo E; de los Santos AR; di Girolamo G
    Biopharm Drug Dispos; 1990; 11(1):77-83. PubMed ID: 2322638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman ; K H Y; Jia Woei W
    Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: application to a pharmacokinetic study in healthy volunteers.
    Yeung PK; Montague TJ; Tsui B; McGregor C
    J Pharm Sci; 1989 Jul; 78(7):592-7. PubMed ID: 2778663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability of two tablet preparations of diltiazem in healthy volunteers.
    De Bernardis E; Candido P; Lorefice R; Picari M; Rizza V
    Arzneimittelforschung; 1992 Jan; 42(1):25-7. PubMed ID: 1586376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pharmacokinetics, bioavailability and dose linearity of diltiazem in healthy volunteers.
    Hutt V; Janik F; Kappler J; Pabst G; Ravelli V; Maccari M; Jaeger H
    Arzneimittelforschung; 1993 Jul; 43(7):737-43. PubMed ID: 8369005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration.
    Sista S; Lai JC; Eradiri O; Albert KS
    J Clin Pharmacol; 2003 Oct; 43(10):1149-57. PubMed ID: 14517197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic determination of diltiazem and two of its metabolites in plasma using a short alkyl chain silanol deactivated column.
    Rutledge DR; Abadi AH; Lopez LM; Beaudreau CA
    J Chromatogr; 1993 May; 615(1):111-6. PubMed ID: 8340449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations.
    Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A
    J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state dose proportionality of a once-a-day sustained-release diltiazem hydrochloride formulation in healthy subjects.
    Ziemniak J; Colligon I; Heald D
    Clin Ther; 1992; 14(2):158-65. PubMed ID: 1611640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and pharmacokinetics of a new sustained-release formulation of diltiazem.
    Thiercelin JF; Necciari J; Caplain H; Cournot A; Combes M; Desmolin H; Flouvat B
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S31-7. PubMed ID: 1706011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
    Scheiwe MW; Lankhaar G; Kleinbloesem CH
    Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability study of diltiazem and two of its metabolites using a high performance liquid chromatographic method.
    Caillé G; Dubé LM; Théorêt Y; Varin F; Mousseau N; McGilveray IJ
    Biopharm Drug Dispos; 1989; 10(1):107-14. PubMed ID: 2923956
    [No Abstract]   [Full Text] [Related]  

  • 14. High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma. Application to pharmacokinetics.
    Goebel KJ; Kölle EU
    J Chromatogr; 1985 Dec; 345(2):355-63. PubMed ID: 4086603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatment.
    Bialer M; Hadad S; Golomb G; Barel S; Samara E; Abu Salach O; Berkman N; Danenberg HD; Ben David J; Caron D
    Biopharm Drug Dispos; 1994 Jan; 15(1):45-52. PubMed ID: 8161715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of diltiazem and its metabolites in dogs after oral administration of a multiparticulate sustained-release preparation.
    Murata K; Yamahara H; Noda K
    Pharm Res; 1993 Aug; 10(8):1165-8. PubMed ID: 8415402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of diltiazem hydrochloride in human serum by high-performance liquid chromatography.
    Chaudhary RS; Gangwal SS; Avachat MK; Shah YN; Jindal KC
    J Chromatogr; 1993 May; 614(2):261-6. PubMed ID: 8314938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
    Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J
    J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous assay of propranolol, diltiazem and metabolites of diltiazem in human plasma by liquid chromatography.
    Ververs FF; Schaefer HG; Lefevre JF; Lopez LM; Derendorf H
    J Pharm Biomed Anal; 1990; 8(6):535-9. PubMed ID: 2093390
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of diltiazem in patients with liver cirrhosis.
    Kurosawa S; Kurosawa N; Owada E; Soeda H; Ito K
    Int J Clin Pharmacol Res; 1990; 10(6):311-8. PubMed ID: 2099357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.